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Background. P[6] rotaviruses have been circulating with a high prevalence in African and, to a more limited extent, Asian coun-
tries, but they have not been highly prevalent in other parts of the world.
Methods. To investigate the genomic relationship between African and Asian human P[6] rotaviruses and P[4] and P[8] rota-
viruses circulating worldwide, we sequenced 39 P[6] strains, collected in Ghana, Mali, Kenya and Bangladesh, providing the largest
data set of P[6] rotavirus genomes isolated in low-income countries or anywhere else in the world that has been published thus far.
Results. Overall, the data indicate that the genetic backbone of human P[6] strains from the low-income countries are similar to
those of P[4] or P[8] strains circulating worldwide.
Conclusions. The observation that gene segment 4 is the main differentiator between human P[6] and non-P[6] strains suggests
that the VP4 spike protein is most likely one of the main reasons preventing the rapid spread of P[6] strains to the rest of the world
despite multiple introductions. These observations reinforce previous ﬁndings about the receptor speciﬁcity of P[6] rotavirus strains.
Keywords. group A rotavirus; vaccine-preventable diseases; epidemiology; gastrointestinal disease; zoonosis; P[6] genotype;
complete genome analyses; clinical trial samples.
Group A rotavirus is the most important causative agent of
gastroenteritis in both infants and young animals worldwide,
resulting in a high mortality and burden of disease, mainly in
low-income countries [1]. However, because the incidence of ro-
tavirus gastroenteritis is similar in both high- and low-income
countries, it is unlikely that improvements in hygiene alone will
reduce the burden of disease. Fortunately, the global burden of
disease in humans has dropped dramatically since the introduc-
tion of rotavirus vaccines in the infant immunization schedules
of most countries [2]. There are currently 2 human oral rotavirus
vaccines licensed worldwide: the human attenuated rotavirus
vaccine (Rotarix) and the pentavalent rotavirus vaccine (PRV;
RotaTeq). The latter contains human-bovine reassortant strains
and both vaccines have proven to be safe and efﬁcacious in
preventing severe gastroenteritis due to rotavirus in European
and American regions [3, 4]. However, both vaccines are less ef-
ﬁcacious in preventing severe gastroenteritis due to rotavirus in
Africa and Asia [5]. For example, the vaccine efﬁcacy in clinical
trials conducted between March 2007 and March 2009 in Ghana,
Kenya, Mali, Vietnam, and Bangladesh was only 39.3% (95%
conﬁdence interval [CI], 19.1%–54.7%) [6–9]. To explain this
observation, multiple factors have been suggested, such as host
population–associated factors related to overall health conditions
(eg, malnutrition, level of maternal antibodies, or coinfecting
pathogens) or the circulation of different genotypes in low-in-
come countries as compared to high-income countries [10]. A
full genome-based classiﬁcation of rotavirus consists of 11 differ-
ent genotypes, one for each of the 11 rotavirus gene segments
[11]. Based on the sequences of the 2 outer capsid proteins, the
glycoprotein VP7 and the spike-protein VP4, G and P genotypes
can be determined. Especially the P[6] genotype seems to have a
relative higher prevalence in low-income countries as compared
to high-income countries, where P[6] strains are only sporadi-
cally detected [12–15].The P[6] genotype is believed to be of por-
cine origin but is already circulating for decades in the human
population [16].The P[6] genotype is one of the 3 major P geno-
types found in human rotaviruses, next to P[8] and P[4] [17].
However, the P[6] genotype is worldwide by far the least preva-
lent of the 3 VP4 genotypes and is genetically and antigenically
more distantly related to P[8] and P[4] than P[8] and P[4] are
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related to each other [18,19]. In general, P[8] and P[4] rotaviruses
are found in combination with a Wa-like (genotype 1) and a DS-
1–like (genotype 2) genotype constellation, respectively, while
P[6] rotaviruses are found with both backgrounds [20].
Previous studies have suggested a link between susceptibility
for rotavirus infections and the histo-blood group antigens phe-
notypes of the host [21, 22]. More speciﬁcally, the surface spike
protein VP8* (one of the trypsin cleavage products of VP4) inter-
acts with the secretor histo-blood group antigens that may func-
tion as ligands or receptors for rotavirus attachment to host cells.
Depending on the P genotype, different histo-blood group anti-
gen binding speciﬁcities were found, with P[4] and P[8] strains
recognizing both the common Leb as the H-type 1 antigens,
while the P[6] rotaviruses exclusively recognize the H-type
1. Therefore, so-called nonsecretors—individuals who have an in-
active α-1, 2 fucosyltransferase and therefore do not synthesize the
H-type 1 antigen—are believed to be nonsusceptible to infection
with P[6] rotaviruses. Complementary to this observation,
Nordgren et al observed that P[6] rotaviruses preferentially infect
Lewis-negative children [23]. The fact that the nonsecretor phe-
notype is found in about 20% of European and North American
populations, while the number of nonsecretors is much lower in
Africa, might explain why rotavirus strains with the P[6] genotype
could have a selective evolutionary disadvantage outside Africa.
During phase 3 clinical trials of PRV in Ghana, Kenya, Mali,
Vietnam, and Bangladesh, 24.3% (192) of 790 rotavirus-positive
G- and P-typed fecal samples contained P[6] strains. Despite
the epidemiological importance of these P[6] strains, previous ep-
idemiological studies conducted in the clinical trial site countries
(Mali, Ghana, Kenya, Bangladesh, and Vietnam) are scarce and
are often based on multiplex instead of sequencing techniques
for genotyping (Table 1). These studies have indicated a high prev-
alence of P[6] strains in all 5 countries, with a prevalence of up to
84.8% reported by Armah et al [48]. Little is known about the ge-
netic composition of African or Asian P[6] rotavirus strains be-
cause only a small number of complete P[6] rotavirus genomes
from these regions have been determined to date. However, in re-
cent years more andmore studies describing complete genomes of
P[6] strains have been published. Some examples include studies
conducted in Cameroon, Malawi, and Ghana, which reported 14,
11, and 2 complete P[6] rotavirus genomes, respectively [49–51].
In this study, we investigated the genomic relationship be-
tween human P[6] rotavirus strains and the more conventional
non-P[6] rotaviruses (G1P[8], G2P[4], G3P[8], G4P[8], G9P[8],
and G12P[8]), to interpret the lower vaccine efﬁcacy in low-in-
come countries and to determine whether the decreased success
of the P[6] strains to spread around the world can be explained
by differences in their genetic background. Therefore, we deter-
mined the complete genome of 39 P[6] rotavirus strains isolated
during the clinical trials of the PRV in Africa and Asia [8, 9],
resulting in the largest data set known today of complete P[6]
rotavirus genomes isolated in low-income countries.
METHODS
Study Design
The samples characterized in this study were collected during a
randomized, placebo-controlled phase 3 trial (clinical trials reg-
istration NCT00362648) conducted between 28 April 2007 and
31 March 2009 in 5 different clinical trial sites. The 3 sites in
sub-Saharan Africa were located in Kenya (Kenya Medical Re-
search Institute, in collaboration with the Centers for Disease
Control and Prevention), Ghana (Noguchi Memorial Institute
for Medical Research, in collaboration with the Navrongo
Health Research Centre), and Mali (Center for Vaccine Devel-
opment, in collaboration with the University of Maryland). The
2 sites in Asia were located in Bangladesh (International Centre
for Diarrhoeal Disease Research) and Vietnam (National Insti-
tute of Hygiene and Epidemiology; International Vaccine Insti-
tute). Detailed descriptions of the study design of the clinical
trial have been reported elsewhere [6, 7]. Brieﬂy, a subset of
the rotavirus positive, G- and P-typed fecal specimens collected
during the phase 3 clinical trial were selected by Merck and
PATH for complete genome sequencing, based on the following
criteria: (1) samples had to contribute to the per-protocol efﬁ-
cacy analysis (ie, cases had to occur >14 days after receipt of the
third dose of PRV or placebo), (2) all observed G genotypes de-
tected in combination with the P[6] genotype during the phase
3 clinical trial needed to be represented, (3) a sufﬁcient stool
sample with a positive enzyme-linked immunosorbent assay
result had to be available, and (4) permission from central
and local institutional review boards and local authorities to
perform the analyses was granted. Unfortunately, rotavirus-
positive samples from Vietnam could not be included in our
study because of the lack of approval from the local medical eth-
ical committees. Of the 192 P[6] rotavirus strains identiﬁed dur-
ing the phase 3 clinical trials of PRV in sub-Saharan Africa and
Southeast Asia, 39 P[6] rotavirus strains collected in Ghana
(n = 14), Mali (n = 18), Kenya (n = 2), and Bangladesh (n = 5)
were selected on the basis of the criteria mentioned above for
full-genome sequencing. Of these 39 stains, 19 and 20 samples
were isolated from study participants belonging to the placebo
and vaccine groups, respectively (Table 1).
Sequencing and Data Analysis
Double-stranded RNA was extracted from 140 µL of 20% raw
stool suspensions, using the QIAamp Viral RNA mini-kit
(Qiagen/Westburg, Leusden, the Netherlands) according to
the manufacturer’s instructions. Subsequently, RNA extracts
were denatured at 95°C for 2 minutes ( followed by cooling
on ice), and reverse transcription–polymerase chain reaction
(RT-PCR) analysis was performed using the Qiagen One Step
RT-PCR kit (Qiagen/Westburg) on the Biometra T3000 ther-
mocycler (Biometra, Westburg, the Netherlands). The initial
RT step (50°C for 30 minutes) was followed by PCR activation
(at 95°C for 15 minutes), 35 cycles of ampliﬁcation (at 94°C for
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30 seconds, at 50°C for 30 seconds, and at 72°C for 1.5 minutes
[for VP7, VP6, NSP2, NSP3, NSP4, and NSP5] or 6 minutes
[for VP1, VP2, VP3, VP4, and NSP1]), with a ﬁnal extension
at 72°C for 10 minutes. Primers used to amplify all gene seg-
ments were described elsewhere [52]. All 11 amplicons were
pooled, taking into account the size of each gene segment and
the yield obtained per RT-PCR analysis. Samples were se-
quenced on the 454 Roche GS-FLX sequencing platform. The
sequence reads obtained were initially mapped against a VP7
and VP4 matching the already known G and P genotype of
each sample completed with a Wa- or DS-1 background in
Mira 3.4.0 or using the CLC Genomics Workbench 7.0. If nec-
essary, a de novo assembly was performed. Sites with insufﬁ-
cient sequence read coverage after combining the reference
mapping and the de novo assembly results were resequenced
using traditional Sanger sequencing. The obtained consensus
sequences were submitted to GenBank (accession numbers
are available in Figure 1) and aligned with a set of rotavirus
genomes and manually edited for insertions and deletions
in homopolymer regions. Nucleotide sequences for every gene
segment were aligned together with those of strains from
GenBank collected all over the world and were analyzed phylo-
genetically, using the maximum likelihood method with the
best ﬁt model in MEGA 6 [53]. Bootstrap resampling analysis
(500 replicates) was performed to measure the reliability of
the tree topologies.
RESULTS
Genetic analyses revealed that P[6] strains were associated with
a wide range of G genotypes: G2 (n = 17), G3 (n = 7), G8 (n = 7),
G12 (n = 5), G1 (n = 2), and G9 (n = 1). In Figure 1, the com-
plete genotype constellation of all analyzed P[6] rotavirus
strains collected during the phase 3 clinical trial in Africa and
Asia is shown. The 7 P[6] strains associated with a G8 genotype
Table 1. Overview of Epidemiological Studies Conducted in Humans in Ghana, Kenya, Mali, Vietnam, and Bangladesh in Which P[6] Rotavirus Strains
Were Detected
Country, Period of Collection
Strains Recovered G Genotypes Among P[6] Strain, No.
Reference(s)Overall, No. P[6], No. (%) 1 2 3 4 5 8 9 10 11 12 Gx Mix
Bangladesh
Jan 2008–Sep 2009 50 11 (22) 0 1 0 0 0 0 1 0 0 9 0 0 [24]
Apr 2007–Mar 2009 154 6 (3.9) 1 0 0 0 0 0 1 0 0 4 0 0 [8]
Jun 2006–May 2012 1963 22 (1.1) 3 1 0 0 0 0 4 0 0 8 0 6 [25]
2006–2009 166 20 (12) 3 1 0 0 0 0 9 0 0 7 0 0 [26]
Aug 2005–Jul 2007 114 9 (7.9) 1 2 0 0 0 0 1 0 0 4 1 0 [27]
Jul 2005–Jun 2006 145 24 (16.6) 2 1 0 0 0 0 0 0 0 12 4 5 [28]
Jul 2004–Jun 2006 60 7 (11.7) 0 0 0 0 0 0 0 0 0 0 0 0 [29]
2005–2006 30 3 (10) 0 0 0 0 0 0 0 0 0 0 0 0 [30]
Jan 2005–Jun 2006 71 14 (19.7) 6 0 0 0 0 0 0 0 0 0 0 0 [31]
2004–2005 284 1 (0.4) 0 0 0 0 0 0 1 0 0 0 0 0 [32]
Jul 2004–Jun 2006 155 47 (30.3) 9 3 0 1 0 0 5 0 0 4 1 24 [33]
Jan 2001–May 2006 456 35 (7.7) 3 1 0 0 0 0 9 0 1 21 0 0 [34]
1992–1997 351 61 (17.4) 5 3 0 10 0 0 37 0 0 0 1 5 [35]
Ghana
Jan 2004–Jan 2005 70 28 (40) 1 3 4 0 0 0 7 0 0 0 10 2 [36]
Aug 2007–Feb 2011 624 218 (34.9) 23 45 56 5 0 0 14 23 0 1 35 16 [37, 38]
Apr 2007–Mar 2009 138 39 (28.3) 0 16 15 0 0 8 0 0 0 0 0 0 [9]
Nov 2005–Jan 2006 142 8 (5.6) 8 0 0 0 0 0 0 0 0 0 0 0 [39]
Jul 1998–Mar 2000 238 70 (29.4) 7 43 6 0 0 6 8 0 0 0 0 0 [40]
Jan 1999–Apr 1999 46 39 (84.8) 0 23 0 0 0 2 0 0 0 0 8 6 [41]
Aug 1998–Dec 1998 50 12 (24) 1 5 3 0 0 0 0 0 0 0 0 3 [42]
Kenya
Aug 2012–Jul 2013 36 7 (19.4) 0 0 0 0 0 0 5 0 0 0 0 2 [43]
Sep 2009–Aug 2011 138 11 (22) 0 0 0 0 0 0 7 0 0 4 0 0 [44]
Apr 2007–Mar 2009 89 25 (16.2) 2 0 0 0 0 21 2 0 0 0 0 0 [9]
2002–2004 558 74 (13.3) 9 0 0 0 0 33 12 0 0 0 5 15 [45]
2000–2002 108 17 (15.7) 3 1 0 0 0 5 2 0 0 0 1 5 [46]
Jan 2000–Mar 2000 20 2 (10) 1 0 0 0 0 0 1 0 0 0 0 0 [47]
Mali
Apr 2007–Mar 2009 366 120 (32.8) 22 81 0 0 0 17 0 0 0 0 0 0 [9]
Abbreviation: Gx, undetermined G genotype.
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have been analyzed in detail elsewhere, showing multiple gene
segments of animal origin [52].
Analyses of the non-G8 P[6] rotaviruses showed that the
large majority (30 of 32) possessed either a complete Wa-like
Figure 1. Genotype constellation and GenBank accession numbers of selected P[6] rotavirus strains isolated in Ghana, Kenya, Mali, and Bangladesh. The red genotypes are
of typical human DS-1–like rotavirus origin, the P[6] VP4 genotype is yellow, and blue is used to indicate gene segments of distinct animal (most likely bovine or similar) origin.
In addition, green is used for Wa-like genotypes, and different shades of green are used for the VP7 G genotypes usually found with a Wa-like backbone. This figure is available
in black and white in print and in color online.
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or DS-1–like backbone, with both exceptions containing Wa-
like gene segments in a DS-1–like backbone. First, strain
RVA/Human-wt/GHA/Ghan-105/2009/G3P[6] not only pos-
sessed the G3 genotype (usually associated with a Wa-like geno-
type constellation), but also contained both Wa-like NSP2 (N1)
and NSP5 (H1) gene segments in a DS-1-like genetic back-
ground. Second, strain RVA/Human-wt/KEN/Keny-061/2008/
G9P[6] possessed the G9 genotype (commonly found with a
Wa-like genotype constellation), as well as Wa-like NSP5
(H1) gene segment, in a DS-1–like background.
The P[6] rotavirus strains isolated in Bangladesh (n = 5) had
a complete Wa-like backbone (in combination with G12), while
most rotavirus strains from sub-Saharan Africa were DS-1 like
(in combination with G1, G2, G3, or G9). Only 1 African P[6]
strain (RVA/Human-wt/MLI/Mali-075/2008/G1P[6]) was
found to posses a complete Wa-like genotype constellation.
Seven entirely DS-1–like African rotavirus strains possessed a
VP7 G genotype atypical for rotaviruses with a DS-1–like back-
ground, including 1 G1 and 6 G3 strains.
Figure 2A shows that the investigated African and Asian P[6]
strains could be subdivided into 3 clusters based on geograph-
ical location of isolation: a West African cluster (containing
rotaviruses from Ghana and Mali), a Kenyan cluster, and a Ban-
gladeshi cluster. However, the genetic distance between each
cluster was <5%, and all of them clustered closely to other
human contemporary P[6] rotaviruses isolated all over the
world. The P[6] strains analyzed in this study were found
with a wide variety of different VP7 G genotypes, representing
the most prevalent G genotypes in humans (Figure 2B). The
only missing common human G genotype was G4, which was
not detected during the clinical trial. The majority of P[6]
strains analyzed in this study possessed the G2 genotype and
Figure 2. Phylogenetic dendrogram based on the nucleotide sequence of the VP4 (A) and VP7 (B) genes. Bootstrap values (500 replicates) of >70 are shown. Rotaviruses
analyzed in this study are indicated with a circle color coded according to country of origin. This figure is available in black and white in print and in color online.
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were isolated in Mali and Ghana. Within the G2 genotype, only
limited genetic diversity was observed, despite the fact that these
strains were isolated in different years and at distinct geograph-
ical locations. The second most prevalent G genotype was G8,
which was isolated in all 3 investigated African countries and
showed the highest genetic diversity within the different G ge-
notypes [52]. No genetic diversity was found within the ana-
lyzed Ghanaian G3 strains, which were all isolated in 2009.
The Bangladeshi P[6] rotavirus strains were exclusively found
in combination with the G12 genotype and are closely related
to G12 strains found around the world. Two G1P[6] rotavirus
strains were characterized in this study, both isolated in Mali.
Strains Mali-075 and Mali-120 share 99.5% identity although
they were isolated in the 2 years spanning the clinical trial pe-
riod, 2008 and 2009. The G9P[6] strain sequenced in this study
clustered together with G9 rotaviruses isolated in different parts
of the world.
Figure 3A shows that the NSP4 gene segments of the 39 in-
vestigated P[6] strains clustered in NSP4 genotypes: E1 and E2.
The genetic diversity among the 6 E1 rotavirus strains was
0.0%–2.4%, and they were closely related to contemporary
human rotavirus strains isolated all over the world. The E2 ge-
notype strains were divided into 3 clusters. The largest E2 clus-
ter contained all Malian rotavirus strains and the majority of the
Ghanaian strains and was closely related to typical contempo-
rary human DS-1–like rotavirus strains. The 2 smaller clusters,
containing rotavirus strains from Kenya (Keny-061 and Keny-
078) or Ghana (Ghan-009, Ghan-060, Ghan-108, Ghan-113,
and Ghan-149) were most closely related to unusual human
and animal rotavirus strains with typical bovine/animal VP7
(G6, G8, and G10) and VP4 (P[5], P[11], or P[14]) genotypes.
Previous complete genome analyses of these unusual human
and animal rotavirus strains revealed a complete or partial
bovine-like rotavirus genome constellation, underscoring the
animal origin of these NSP4 genes, comprising 18% of the cur-
rently investigated human P[6] strains.
The phylogenetic tree of NSP2 (Figure 3B) shows 7 strains
(all 5 Bangladeshi strains, Mali-075, and Ghan-105) clustering
Figure 3. Phylogenetic dendrogram based on the nucleotide sequence of the NSP4 (A) and NSP2 (B) gene. Bootstrap values (500 replicates) of >70 are shown. Rotaviruses
analyzed in this study are indicated with a circle color coded according to country of origin. This figure is available in black and white in print and in color online.
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Figure 4. Phylogenetic dendrogram based on the nucleotide sequence of the VP6 (A) and VP1–3 (B–D) genes. Bootstrap values (500 replicates) of >70 are shown. Rotaviruses
analyzed in this study are indicated with a circle color coded according to country of origin. This figure is available in black and white in print and in color online.
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within the N1 genotype, together with contemporary human
Wa-like rotaviruses isolated around the world.
Interestingly, the NSP2 N2 genotype contained 4 clusters,
one containing the majority of Ghanaian strains and the
Kenyan strains clustering closely to human rotavirus strains,
possessing a typical DS-1–like genotype constellation. The
remaining 3 clusters included (1) the majority of closely related
Malian NSP2 gene segments, together with Ghan-053; (2) all 4
Malian G8P[6] strains; and (3) the 2 Ghanaian G8P[6] strains.
All analyzed strains of these 3 clusters were only distantly relat-
ed to typical human rotavirus strains, suggesting an animal or-
igin of these NSP2 gene segments.
The remaining gene segments, VP6, VP1–3, NSP1, NSP3,
and NSP5, showed a similar clustering pattern for all 32 non-
G8 P[6] strains. As illustrated in Figures 4 and 5, these 32 rota-
viruses were found either in combination with genotype 1 or
with genotype 2. Only within the NSP5 tree (Figure 5C) was
an additional genotype found (H3) for the 2 G8P[6] strains
from Ghana (Ghan-113 and Ghan-149). For each of the geno-
type 2 clusters in the phylogenetic trees of the gene segments
VP6, VP1–3, NSP1, NSP3, and NSP5, a west/east cluster
deviation was shown for the African strains, although only
minor variations were noted between the strains isolated in
this study. For all these genotypes (I2, R2, C2, M2, T2, and
H2), a close phylogenetic relationship was found between our
strains and contemporary human DS-1–like strains, without ev-
idence for animal rotavirus gene segments.
For all 7 gene segments, the genotype 1 cluster contained all 5
strains isolated in Bangladesh, together with strain Mali-045,
the only African strain found in this study with a complete
Wa-like background. Within the H1 genotype, 2 additional
strains were found, Ghan-105 and Keny-061, both possessing
an H1 gene segment in a DS-1–like background. Overall, the
analyzed strains clustered closely to other contemporary
human Wa-like strains isolated around the globe.
DISCUSSION
This study describes the largest data set of complete P[6] rota-
virus strains, isolated in a low-income country setting, as well as
in a clinical trial setting, thus far. In total, 39 P[6] strains were
completely sequenced using next-generation sequencing tech-
niques, showing a large diversity within the G genotypes. This
Figure 5. Phylogenetic dendrogram based on the nucleotide sequence of the NSP1 (A), NSP3 (B), and NSP5 (C) genes. Bootstrap values (500 replicates) of >70 are shown.
Rotaviruses analyzed in this study are indicated with a triangle color coded according to country of origin. This figure is available in black and white in print and in color online.
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observation indicates that reassortment events involving the
VP7 gene segment frequently happen. A clear example of this
involves the 2 strains Mali-075 and Mali-120, both of which
contained highly similar G1P[6] genotypes in combination
with a completely different genotype constellation (Figures 1
and 2). In contrast to the large genotype diversity found within
the VP7 gene, only limited diversity was observed within the
genetic backbone of the analyzed P[6] strains. The majority
of strains possessed a genetic backbone belonging to one of
two typical rotavirus genotype constellations found in humans
worldwide, Wa-like (I1-R1-C1-M1-A1-N1-T1-E1-H1) or DS-1
like (I2-R2-C2-M2-A2-N2-T2-E2-H2). Only a limited amount
of reassortment events between DS-1–like and Wa-like gene
segments were observed, more speciﬁcally in the nonstructural
NSP2 and NSP5 genes. Interactions between NSP2 and NSP5
are required to form viroplasms, cytoplasmatic inclusions in
which rotavirus genome replication occurs [54]. Evidence for
intergenogroup reassortment between Wa-like and DS-1–like
human rotaviruses for both NSP2 and NSP5 genes have been
reported in previous studies, indicating that NSP2 and NSP5
genes are more prone to be exchanged between different rotavi-
rus strains [20, 55]. One study even described the presence of a
vaccine-derived NSP2 gene that had reassorted into human
Wa-like rotaviruses [56]. These observations highlight the fact
that reassortment events between vaccine strains and circulating
human strains are likely to happen in the future, stressing the
importance of continued surveillance both before and after vac-
cine introduction. However, no vaccine-derived gene segments
were found in this study.
The data from this study suggest the circulation of completely
unrelated P[6] rotavirus populations in Asia and Africa. All
P[6] rotavirus strains isolated in Bangladesh possessed a com-
plete Wa-like backbone and were found together with G12,
while 26 of 27 rotavirus strains from sub-Saharan Africa were
found together with a DS-1-like genotype constellation and
G1, G2, G3, or G9. The limited number of complete P[6] ge-
nomes available from Asia and sub-Saharan Africa thus far
does not allow us to further investigate whether this observation
is an artifact of the selected samples or a more general fact. Ad-
ditional large sequencing studies in low-income countries are
needed to draw more-general conclusions. With the recent ad-
vancements in next-generation techniques, making it possible
to sequence larger amounts of genomes at a reasonable cost,
this aim becomes more and more feasible.
Interestingly, several of these P[6] rotavirus strains (in com-
bination with G1, G2, or G9) appeared to have a single gene seg-
ment (NSP2 or NSP4) with a potential bovine-like rotavirus
origin (Table 1), in contrast to the high number of gene seg-
ments of animal origin found within G8P[6] rotaviruses [52].
However, potential bovine-like rotavirus gene segments have
not exclusively been encountered in rotavirus strains carrying
the P[6] genotype, but have also been found in rotavirus strains
carrying the P[4] and P[8] genotypes cocirculating during the
clinical trial (data not shown). In addition, potential bovine-
like rotavirus gene segments have been found in non-P[6]
strains isolated in a number of countries worldwide, including
Brazil, Pakistan, Iraq, the Democratic Republic of the Congo,
Australia, and Belgium [57–60].
Taken together, these data suggest that the genetic backbone
of the vast majority of the P[6] rotavirus strains circulating
in Mali, Ghana, Kenya, and Bangladesh are very similar to
the worldwide cocirculating P[4]/DS-1-like or P[8]/Wa-like ro-
tavirus strains [20].Therefore, it is unlikely that the difference in
vaccine efﬁcacy between high- and low-income countries is the
result of a different genetic composition of circulating rotavirus
strains. However, based on the complete genomes determined
in this study, the VP4 gene segment belonging to the P[6] ge-
notype seems to be the main determinant of whether certain
strains are able to rapidly spread worldwide among the
human population over longer periods. Therefore, it is likely
that the P[6] segment by itself may be responsible for the re-
striction of these strains to the African and Asian continents.
One plausible explanation for this observation would be the
difference in histo-blood group antigens phenotypes present
in white and nonwhite populations. Further investigation is
needed to determine whether histo-blood group antigens can
be related to host susceptibility/resistance factors for (P[6]) ro-
taviruses, as been proven to be the case for susceptibility to nor-
ovirus infection [61]. Potentially, the number of susceptible
people (eg, people who synthesize the H-type 1 antigen) outside
Africa and Asia might not be high enough for P[6] strains to
become epidemiologically important and successfully compete
with P[4] or P[8] strains.
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